Dysregulation of the PI3K/Akt pathway occurs at multiple levels in AD and extends beyond Nrf2 signaling, as oligomeric amyloid-beta peptides can activate PI3K/Akt and the mTORC1 pathway. The gene discussed is NFE2L2; the disease is Alzheimer disease.